Please enable Javascript to use all features and improve your user experience.
DGTI 2022
Programme
People
Search
DE
All people
Prof. Dr. med Johannes Oldenburg
Sort by Type
Date
Chair
23/09/2022
13:30
–
15:00
Vortragssitzung
Joint GTH
Arnold Schönberg
Speaker
21/09/2022
15:40
–
15:50
6 Min.
4 Min.
Abstractvortrag
VS-7-4
Efficacy and safety of valoctocogene roxaparvovec gene transfer for severe hemophilia A: Results from the GENEr8-1 two-year analysis
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 12. Zelltherapie und Gentherapie
22/09/2022
17:15
–
17:20
3 Min.
2 Min.
Poster
PS-4-12
Interim 52-Week Analysis of Immunogenicity to the Vector Capsid and Transgene-Expressed Human FVIII in GENEr8-1, a Phase 3 Clinical Study of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 12. Zelltherapie und Gentherapie
Further involvements
21/09/2022
15:30
–
15:40
6 Min.
4 Min.
Abstractvortrag
VS-7-3
Structural investigations into coagulation factor VIII full-length and B domain
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 9. Hämotherapie
21/09/2022
15:40
–
15:50
6 Min.
4 Min.
Abstractvortrag
VS-7-4
Efficacy and safety of valoctocogene roxaparvovec gene transfer for severe hemophilia A: Results from the GENEr8-1 two-year analysis
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 12. Zelltherapie und Gentherapie
22/09/2022
17:15
–
17:20
3 Min.
2 Min.
Poster
PS-4-12
Interim 52-Week Analysis of Immunogenicity to the Vector Capsid and Transgene-Expressed Human FVIII in GENEr8-1, a Phase 3 Clinical Study of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 12. Zelltherapie und Gentherapie
22/09/2022
17:20
–
17:25
3 Min.
2 Min.
Poster
PS-3-11
Rivaroxaban levels in plasma show greater inter-individual variation than apixaban levels in treatment of venous thromboembolism
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 9. Hämotherapie
22/09/2022
17:35
–
17:40
3 Min.
2 Min.
Poster
PS-3-14
Effect of GABARAP protein on the intracellular distribution of FVIII
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie
22/09/2022
17:45
–
17:50
3 Min.
2 Min.
Poster
PS-3-16
Whole genome expression analysis resolves the correlation between genetic knockout of single genes and the obtained phenotype in relation to FVIII secretion
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy